Search Results
Jun 03, 2026, 08:00 ET Honeywell Aerospace to Host Inaugural Investor Day
conditions related thereto; (ii) the possibility that the spin-off transaction will not be completed within the anticipated time period or at all; (iii) the possibility that the spin-off transaction will not achieve its intended benefits; (iv) the impact of the spin-off transaction on Honeywell's and Honeywell
More news about: Honeywell
Jun 03, 2026, 07:07 ET Natural Grocers® Celebrates Oklahoma Day with a Special Gift and Savings June 7-9, 2026
details via {N}power email or app. Must present phone number at checkout to accumulate towards the minimum requirement in one transaction.[iii] Sign up by 6/4/2026 to receive this coupon via email or app. {N}power offers are available only to registered members and are subject to program
More news about: Natural Grocers by Vitamin Cottage, Inc.
Jun 03, 2026, 07:01 ET VERSABANK REPORTS STRONG SECOND QUARTER RESULTS: STRONG US SRP GROWTH DRIVES 27% YEAR-OVER-YEAR INCREASE IN REVENUE AND NET INTEREST INCOME, 45% YEAR-OVER-YEAR GROWTH IN ADJUSTED (CORE) NET INCOME
** Capital management and leverage measures are in accordance with OSFI's Capital Adequacy Requirements and Basel III Accord.
More news about: VersaBank
Jun 03, 2026, 06:26 ET Precision Cardiovascular Appoints Brian Fahey, Ph.D., as Independent Director to the Board
commercialization and acquisition. He brings strong technical depth, strategic judgment, and operational leadership, particularly in highly regulated Class III implantable device markets.Dr. Fahey has founded and led multiple medical device companies, including Adona Medical and Niveus Medical. As founder
More news about: Precision Cardiovascular
Jun 03, 2026, 06:00 ET ElpasBio Completes Patient Enrollment in Phase III Pivotal Clinical Trial of AlloJoin®
clinical-stage biotechnology company focused on regenerative medicine, today announced it completed patient enrollment in May in its China Phase III pivotal clinical trial of AlloJoin® (lotazadromcel), the allogeneic human adipose-derived mesenchymal stem cell (haMPC) therapy for the treatment
More news about: ElpasBio Holdings
Jun 02, 2026, 23:29 ET Generación Mediterránea S.A. and Central Térmica Roca S.A. Announce Participation Results of their Previously Announced Exchange Offer and Consent Solicitation
to the extent the Exchange Offer is not consummated pursuant to its terms and the Companies and the Ad Hoc Group decide to pursue the Scheme), and (iii) release all of the collateral securing the Existing Notes, direct each of the Existing Notes Trustee, the Argentine Collateral Agent and the Onshore
More news about: Generación Mediterránea S.A. and Central Térmica Roca S.A.
Jun 02, 2026, 22:35 ET WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
operations, and more efficient manufacturing. As of April 30, 2026, WuXi Biologics is supporting 982 integrated client projects, including 78 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.WuXi Biologics regards
More news about: WuXi Biologics
Jun 02, 2026, 22:17 ET Infrastructure AI Targets Multi-Trillion-Dollar Facilities Management with Autonomous AI Agents
and continuously improve performance in real time."At the core of the platform is Infrastructure AI's Infrastructure Intelligence Interphase (III), an AI-driven operational environment designed to replace dashboard-centric building management systems with intelligent autonomous orchestration. Instead
More news about: Infrastructure AI
Jun 02, 2026, 19:11 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 5,42 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $11,6 Miliar
Bitmine tetap didukung oleh kelompok penting beranggotakan investor institusi seperti Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, dan investor pribadi Thomas "Tom" Lee guna mendukung tujuan Bitmine untuk mengakuisisi 5% ETH
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 19:07 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 5,42 millions de tokens et que ses avoirs en cryptomonnaies et en liquidités atteignent 11,6 milliards de dollars
continue de recevoir le soutien d'un groupe d'investisseurs institutionnels de premier plan, dont Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, pour atteindre l'objectif de Bitmine d'acquérir 5 % du nombre total
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 18:40 ET Bitmine Immersion Technologies (BMNR) Công Bố Lượng ETH Nắm Giữ Đạt 5,42 Triệu Token, Đưa Tổng Tài Sản Tiền Mã Hóa và Tiền Mặt Lên Mức 11,6 Tỷ USD
Bitmine hiện vẫn được hỗ trợ bởi một nhóm các nhà đầu tư tổ chức hàng đầu như Cathie Wood của ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital và nhà đầu tư cá nhân Thomas "Tom" Lee nhằm giúp Bitmine đạt mục tiêu sở hữu 5% ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 18:37 ET Bitmine Immersion Technologies (BMNR) gibt bekannt, dass sich der ETH-Bestand auf 5,42 Millionen Token beläuft und die Gesamtbestände an Kryptowährungen sowie die Barreserven 11,6 Milliarden US-Dollar betragen
wird weiterhin von einer Gruppe führender institutioneller Investoren unterstützt, darunter Cathie Wood von ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital und der Privatinvestor Thomas „Tom" Lee, um das Ziel von Bitmine zu unterstützen, 5 % der ETH zu erwerben
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 18:34 ET Bitmine Immersion Technologies (BMNR) kondigt aan dat de ETH-bezittingen zijn gestegen tot 5,42 miljoen tokens, met totale cryptobezittingen en liquide middelen van 11,6 miljard dollar.
Bitmine wordt ondersteund door een vooraanstaande groep institutionele investeerders, waaronder Cathie Wood van ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital en persoonlijke investeerder Thomas 'Tom' Lee ter ondersteuning van Bitmines doel om 5% van alle ETH te verwerven.
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 17:19 ET Whirlpool Announces Upsize and Pricing of Offering of Secured Notes
depositing with the trustee under the Existing Notes Indenture funds sufficient to pay the principal of and interest on such Existing Notes as and when due, (iii) repay the amount outstanding under the Company's existing unsecured revolving credit facility, and (iv) pay fees and expenses in connection with the
More news about: Whirlpool Corporation
Jun 02, 2026, 16:58 ET Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. guided investors toward a Phase III future for pociredir while a $25.1 million facility lease locked the company into infrastructure now stranded by program termination. NEW YORK, June 2, 2026
More news about: Levi & Korsinsky, LLP
Jun 02, 2026, 15:53 ET Marco Pharma International Launches Live Practitioner Forum Series
different discipline, background, knowledge base — that make each of them uniquely important."When Dr. Andreas Marx, Ana Marx, and Isaac Conyers III founded MPI out of an apartment in 1991, the model was never transactional. Practitioners were part of the mission from day one. "Our practitioners are
More news about: Marco Pharma International
Jun 02, 2026, 13:13 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,42 millones de tokens
con el respaldo de un selecto grupo de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor particular Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5 % de ETH.
More news about: Bitmine Immersion Technologies, Inc.
Jun 02, 2026, 13:00 ET Celebrate America's 250th Birthday with Proven Winners® Patriotic Plant Combos
Sky Blue III
More news about: Proven Winners
Jun 02, 2026, 11:55 ET ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine
AMA CPT Editorial Panel Acceptance of Five Category III Codes Establishes Coding Infrastructure for Bilateral Supraorbital-Occipital Neurostimulator Services Ahead of Anticipated Regulatory Submission MINNEAPOLIS, June
More news about: ShiraTronics, Inc.
Jun 02, 2026, 10:01 ET Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight
brand name Jeuveau for cosmetic use. The therapy has completed a Phase II clinical trial for Cervical Dystonia and is expected to advance into a Phase III study. Recently, the company shared topline results at the TOXINS 2024 Conference. In addition, ABP-450 is being explored for several other indications,
More news about: DelveInsight Business Research, LLP
Jun 02, 2026, 09:30 ET Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
sample size in the first-line group requires cautious interpretation and further validation. For Pemigatinib, prior phase II and the most recent phase III data report an ORR of 35.5% in 146 second-line patients and 47.0% in 83 first-line patients. To date, 3HP-2827 has generated preliminary efficacy evidence
More news about: 3H Pharmaceuticals
Jun 02, 2026, 09:00 ET IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
adverse facts concerning the efficacy and safety of its TACTI-004 Phase III clinical trial study. On March 13, 2026, Immutep issued a press release announcing that the Independent Data Monitoring (IDMC) for the TACTI-004 Phase III study recommended that the trial be discontinued following a planned interim
More news about: The Gross Law Firm
Jun 02, 2026, 09:00 ET ZTS DEADLINE: The Gross Law Firm Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline
Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment.DEADLINE:
More news about: The Gross Law Firm
Jun 02, 2026, 09:00 ET AVAV UPCOMING DEADLINE : The Gross Law Firm Alerts AeroVironment, Inc. Stockholders of Securities Class Action - Contact the Firm
ongoing efforts to modernize the Satellite Control Network; (ii) accordingly, defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: July 27, 2026 Shareholders
More news about: The Gross Law Firm
Jun 02, 2026, 09:00 ET RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
manipulation; (ii) the resulting volatility in the market for the Company's ordinary shares exposed Regencell's investors to significant financial risk; (iii) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant
More news about: The Gross Law Firm